Abstract
We used complexes between a fourth generation polyamidoamine (PAMAM) dendrimer and one of two heterocyclic compounds — 1-(6-hydroxyhexyl)-3-(5-phenyl-isoxazole-3-yl)-urea or 5-phenyl-isoxazole-3-carboxylic acid — to reduce oxygen consumption in transverse slices of the hippocampus taken from 4-week old male rats. In vitro electrophysiological experiments revealed that the inhibitory effect of the hypoxic state on the evoked responses was enhanced in the presence of the complexes. The data were analyzed in terms of the potential antitumor effects of these complexes.
[1] Moen, I. and Stuhr, L.E.B. Hyperbaric oxygen therapy and cancer — a review. Target Oncol. 7 (2012) 233–242. http://dx.doi.org/10.1007/s11523-012-0233-x10.1007/s11523-012-0233-xSearch in Google Scholar PubMed PubMed Central
[2] Depret, J., Teboul, J.L., Benoit, G., Mercat, A. and Richard, C. Global energetic failure in brain-dead patients. Transplantation 60 (1995) 966–971. http://dx.doi.org/10.1097/00007890-199511000-0001510.1097/00007890-199511000-00015Search in Google Scholar
[3] Pastorekova, S., Zatovicova, M. and Pastorek, J. Cancer-associated carbonic anhydrases and their inhibition. Curr. Pharm. Design 14 (2008) 685–698. http://dx.doi.org/10.2174/13816120878387789310.2174/138161208783877893Search in Google Scholar PubMed
[4] Kulchitsky, V.A., Talabaev, M.V., Chernov, A.N., Grigoriev, D.G., Demidchik, Y.E., Shcharbin, D.G., Chekan, N.M., Kazbanov, V.V., Gurinovich, T.A., Gordienko, A.I., Sergeeva, E.K., Potkin, V.I. and Kalunov, V.N. Improving the efficiency of chemotherapeutic drugs by the action on neuroepithelial tumors. In.: Glioma — Exploring Its Biology and Practical Relevance (Anirban Ghosh, Ed.) 21 (2011) 465–486. Search in Google Scholar
[5] Kamal, A., Bharathi, E.V., Reddy, J.S., Ramaiah, M.J., Dastagiri, D., Reddy, K., Viswanath, A., Reddy, T.L., Shaik, T.B., Pushpavalli, S.N. and Bhadra, M.P. Synthesis and biological evaluation of 3,5-diaryl isoxazoline/isoxazole linked 2,3-dihydroquinazolinone hybrids as anticancer agents. Eur. J. Med. Chem. 46 (2011) 691–703. http://dx.doi.org/10.1016/j.ejmech.2010.12.00410.1016/j.ejmech.2010.12.004Search in Google Scholar PubMed
[6] Cai, X., Hu, J., Xiao, J. and Cheng, Y. Dendrimer and cancer: a patent review (2006-present). Expert Opin. Ther. Pat. 23 (2013) 515–529. http://dx.doi.org/10.1517/13543776.2013.76120710.1517/13543776.2013.761207Search in Google Scholar PubMed
[7] Shcharbin, D., Dzmitruk, V., Shakhbazau, A., Goncharova, N., Seviaryn, I., Kosmacheva, S., Potapnev, M., Pedziwiatr-Werbicka, E., Bryszewska, M., Talabaev, M., Chernov, A., Kulchitsky, V., Caminade, A.-M. and Majoral, J.-P. Fourth generation phosphorus-containing dendrimers: prospective drug and gene delivery carriers. Pharmaceutics 3 (2011) 458–473. http://dx.doi.org/10.3390/pharmaceutics303045810.3390/pharmaceutics3030458Search in Google Scholar PubMed PubMed Central
[8] Ziemba, B., Matuszko, G., Bryszewska, M. and Klajnert, B. Influence of dendrimers on red blood cells. Cell. Mol. Biol. Lett. 17 (2012) 21–35. http://dx.doi.org/10.2478/s11658-011-0033-910.2478/s11658-011-0033-9Search in Google Scholar PubMed PubMed Central
[9] Lazniewska, J., Milowska, K., Katir, N., El Kadib, A., Bryszewska M., Majoral, J.-P. and Gabryelak, T. Viologen-phosphorus dendrimers exhibit minor toxicity against a murine neuroblastoma cell line. Cell. Mol. Biol. Lett. 18 (2013) 459–478. http://dx.doi.org/10.2478/s11658-013-0100-510.2478/s11658-013-0100-5Search in Google Scholar PubMed PubMed Central
[10] Kulchitsky, V.A., Potkin, V.I., Zubenko, Yu.S., Chernov, A.N., Talabaev, M.V., Demidchik, Y.E., Petkevich, S.K., Kazbanov, V.V., Gurinovich, T.A., Roeva, M.O., Grigoriev, D.G., Kletskov, A.V. and Kalunov, V.N. Cytotoxic effects of chemotherapeutic drugs and heterocyclic compounds at application on the cells of primary culture of neuroepithelium tumors. Med. Chem. 8 (2012) 22–32. http://dx.doi.org/10.2174/15734061279927829810.2174/157340612799278298Search in Google Scholar PubMed
[11] Garkun, Y.S., Yakubovich, N.V., Denisov, A.A., Molchanov, P.G., Emel’janova, A.A., Pashkevich, S.G. and Kulchitsky, V.A. Generation of excitatory postsynaptic potentials in the hippocampus after functional modification of glycosaminoglycans. Bull. Exp. Biol. Med. 145 (2008) 395–397. http://dx.doi.org/10.1007/s10517-008-0100-z10.1007/s10517-008-0100-zSearch in Google Scholar PubMed
[12] Tabata, Y. Nanomaterials of drug delivery systems for tissue regeneration. Meth. Mol. Biol. 300 (2005) 81–100. Search in Google Scholar
© 2013 University of Wrocław, Poland
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.